New Year: Time for Your Memory Screening Appointment
WEDNESDAY, Jan. 11, 2023 (HealthDay News) — Many conditions cause memory issues, and early detection is essential for effective treatment, according to a national Alzheimer’s disease organization.The Alzheimer’s Foundation of America (AFA) encourages…
Learn MoreFDA Approves Second Alzheimer’s Drug, Despite Safety Concerns
FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients.However, the FDA pointed to the dru…
Learn MorePTSD, TBI Interact With APOE ε4 to Raise Alzheimer, Dementia Risk
FRIDAY, Jan. 6, 2023 (HealthDay News) — Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) interact with apolipoprotein E (APOE) ε4 to confer increased prevalence of Alzheimer disease and related dementias (ADRD) in veterans, accor…
Learn MorePatients, Doctors Await FDA Decision on Experimental Alzheimer’s Drug
THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administrat…
Learn MoreCongressional Report Slams FDA, Drugmaker Over Approval of Alzheimer’s Drug Aduhelm
THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to sl…
Learn More5α-Reductase Inhibitors Linked to Depression, but Not Dementia
THURSDAY, Dec. 29, 2022 (HealthDay News) — 5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published online Dec. 22 in JAMA Network Open.Miguel Ga…
Learn MorePasar tiempo en la naturaleza parece ralentizar el Parkinson y el Alzheimer
MARTES, 27 de diciembre de 2022 (HealthDay News) — Vivir en un área con un acceso fácil a parques y ríos parece ralentizar la progresión de unas devastadoras enfermedades neurológicas, como el Alzheimer y el Parkinson.Esta es la conclusión de un nuev…
Learn MoreTime Spent in Nature Appears to Slow Parkinson’s, Alzheimer’s
TUESDAY, Dec. 27, 2022 (HealthDay News) — Living in an area with easy access to parks and rivers appears to slow the progression of devastating neurological diseases, such as Alzheimer’s and Parkinson’s.That’s the conclusion of a new study based on …
Learn MorePsychological Distress May Be Causal Risk Factor for Dementia
TUESDAY, Dec. 20, 2022 (HealthDay News) — Self-reported psychological distress is likely a causal risk factor for subsequent dementia, according to a study published online Dec. 15 in JAMA Network Open.Sonja Sulkava, M.D., Ph.D., from the Finnish Ins…
Learn MoreMake the Holidays Comforting for Loved Ones With Alzheimer’s
SATURDAY, Dec. 17, 2022 (HealthDay News) — Those who have dementia can find the holiday season disorienting, but their loved ones can help.”The holiday season can be both joyful and stressful for all of us, especially individuals living with a dement…
Learn More